Literature DB >> 21929288

Cell signaling and receptors in toxicity of advanced glycation end products (AGEs): α-dicarbonyls, radicals, oxidative stress and antioxidants.

Peter Kovacic1, Ratnasamy Somanathan.   

Abstract

Considerable attention has been paid to the toxicity of advanced glycation end products (AGEs), including relation to various illnesses. AGEs, generated nonenzymatically from carbohydrates and proteins, comprises large numbers of simple and more complicated compounds. Many reports deal with a role for receptors (RAGE) and cell signaling, including illnesses and aging. Reactive oxygen species appear to participate in signaling. RAGE include angiotensin II type 1 receptors. Many signaling pathways are involved, such as kinases, p38, p21, TGF-β, NF-κβ, TNF-α, JNK and STAT. A recent review puts focus on α-dicarbonyl metabolites, formed by carbohydrate oxidation, and imine derivatives from protein condensation, as a source via electron transfer (ET) of ROS and oxidative stress (OS). The toxic species have been related to illnesses and aging. Antioxidants alleviate the adverse effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21929288     DOI: 10.3109/10799893.2011.607171

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  12 in total

Review 1.  Overlapped metabolic and therapeutic links between Alzheimer and diabetes.

Authors:  Waqar Ahmad
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

2.  Soluble receptor and gene polymorphism for AGE: relationship with obesity and cardiovascular risks.

Authors:  Mohamed Rowisha; Manal El-Batch; Thanaa El Shikh; Salwa El Melegy; Hany Aly
Journal:  Pediatr Res       Date:  2016-03-18       Impact factor: 3.756

3.  Hydrogen-rich water inhibits glucose and α,β -dicarbonyl compound-induced reactive oxygen species production in the SHR.Cg-Leprcp/NDmcr rat kidney.

Authors:  Masanori Katakura; Michio Hashimoto; Yoko Tanabe; Osamu Shido
Journal:  Med Gas Res       Date:  2012-07-09

4.  Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training.

Authors:  Sellamuthu S Gounder; Sankaranarayanan Kannan; Dinesh Devadoss; Corey J Miller; Kevin J Whitehead; Kevin S Whitehead; Shannon J Odelberg; Matthew A Firpo; Robert Paine; John R Hoidal; E Dale Abel; Namakkal S Rajasekaran
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

5.  Steap4 attenuates high glucose and S100B-induced effects in mesangial cells.

Authors:  Chao-Tang Chuang; Jinn-Yuh Guh; Chi-Yu Lu; Yeng-Tseng Wang; Hung-Chun Chen; Lea-Yea Chuang
Journal:  J Cell Mol Med       Date:  2015-03-27       Impact factor: 5.310

6.  Neuroprotective effects of SMADs in a rat model of cerebral ischemia/reperfusion.

Authors:  Fang-Fang Liu; Chao-Ying Liu; Xiao-Ping Li; Sheng-Zhe Zheng; Qing-Quan Li; Qun Liu; Lei Song
Journal:  Neural Regen Res       Date:  2015-03       Impact factor: 5.135

7.  Antiglycative Activity and RAGE Expression in Rett Syndrome.

Authors:  Valeria Cordone; Alessandra Pecorelli; Mascia Benedusi; Silvano Santini; Stefano Falone; Joussef Hayek; Fernanda Amicarelli; Giuseppe Valacchi
Journal:  Cells       Date:  2019-02-15       Impact factor: 6.600

Review 8.  The effects of oxidative stress on female reproduction: a review.

Authors:  Ashok Agarwal; Anamar Aponte-Mellado; Beena J Premkumar; Amani Shaman; Sajal Gupta
Journal:  Reprod Biol Endocrinol       Date:  2012-06-29       Impact factor: 5.211

9.  Dab2 attenuates brain injury in APP/PS1 mice via targeting transforming growth factor-beta/SMAD signaling.

Authors:  Lei Song; Yue Gu; Jing Jie; Xiaoxue Bai; Ying Yang; Chaoying Liu; Qun Liu
Journal:  Neural Regen Res       Date:  2014-01-01       Impact factor: 5.135

10.  Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.

Authors:  Simone Pereira-Simon; Gustavo A Rubio; Xiaomei Xia; Weijing Cai; Rhea Choi; Gary E Striker; Sharon J Elliot
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.